Nitric Oxide Synthase Inhibition Prevents Acute Quinolinate-Induced Striatal Neurotoxicity
Quinolinic acid (QUIN) is an endogenous excitotoxin acting on N-methyl-D-aspartate (NMDA) receptors, that leads to neurotoxic damage resembling the alterations observed in Huntington's disease. Two major end-points of QUIN induced neurotoxicity are both circling behavior (CB) and lipid peroxidation (LP). Recently, nitric oxide (NO) has been implicated as a mediator of cell injury in some neurological disorders, thus, NO as a free radical might be involved in QUIN-induced neurotoxicity and oxidative stress. In the present study we evaluated the possible role of NO on QUIN-induced neurotoxicity, by measuring nitric oxide synthase activity (NOS), before and after QUIN-induced damage and by evaluating the effect of NOS inhibition on acute QUIN-induced CB and LP. Rats were striatally microinjected with QUIN (240 nmol/1μl). QUIN administration increased NOS activity by 327% as compared to control values and this enhancement was inhibited by i.v. pretreatment with a NOS inhibitor the NG-nitro-L-arginine methyl ester (L-NAME) (10 mg/kg). QUIN-induced CB was also attenuated by pretreatment of rats with 1, 5, 10 and 15 mg/kg of L-NAME by −37, −55, −62 and −74% vs QUIN respectively. Similarly, L-NAME also reduced by 32% the QUIN-induced LP. These findings suggest that enhanced NOS activity may participate in QUIN-induced neurotoxicity and oxidative stress.
Unable to display preview. Download preview PDF.
- 17.O'Dell, T. J., Hawkins, R. D., Kandel, E. R., and Arancio, O. 1991. Test of the roles of two diffusable substances in long term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88:1185-1289.Google Scholar
- 20.Lipton, S. A., and Stamler, J. S. 1994. Actions of redox congeners of nitric oxide at the NMDA receptor. Neuropharmacol. 33(11):1229-1233.Google Scholar
- 25.Paxinos, G., and Watson, G. 1984. The rat brain in stereotaxic coordinates, Sydney, Academic Press.Google Scholar
- 33.Fisher, R. S. 1991. Introduction to the excitatory amino acid system. Epilepsy. 10:3-8.Google Scholar
- 34.Fisher, R. S. 1991. Glutamate and epilepsy. Neurotransmitters Epilepsy. 11:131-45.Google Scholar
- 37.Jansen, K. L. R., Faull, R. L. M., Dragunow, M., and Synek, B. L. 1990. Alzheimer's disease-changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and apioid receptors an autoradiographic study. Neurosci. 39:613-27.Google Scholar
- 41.Heyes, M. P. 1996. The kinurenine pathway and neurologic disease. Therapeutic strategies. Adv. Exp. Med. Biol. 398:125-9.Google Scholar
- 42.Strijbos, P. J., Leach, M. J., and Garthwaite, J. 1996. Vicious cycle involving Na+ channels, glutamate release and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. Neurosci. Res. 16(16):5004-13.Google Scholar
- 43.Park, S. K., Grzybicki D., Lin, H. L., and Murphy, S. 1994. Modulation of inducible nitric oxide synthase expression in astroglial cells. Neuropharmacol. 33(11):1419-1423.Google Scholar
- 44.Moncada, S., Herman, A. G., and Vanhoutte, P. M. 1987. Endothelium-derived relaxing factor is identified as nitric oxide. Trends Pharmacol. Sci. 8:365-367.Google Scholar
- 45.Galasso, J. M., Bazzett, T. J., Becker, J. B., and Albin, R. L. 1995. Synergistic effect of intraestriatal coadministration of L-NAME and quinolinic acid. Neuro Report. 6:1505-1608.Google Scholar
- 46.Globus, M. Y.-T., Prado, R., Sanchez-Ramos, J., Zhao, Weizhao., Dietrich, W. D., Busto, R., and Ginsberg, M. D. 1995. A dual Role for nitric oxide in NMDA-mediated toxicity in vivo. J. Cerebral Blood Flow and Metabolism. 15:904-913.Google Scholar